The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $9,435,658 in first-year total cost, median $2,331,357.
Most frequent study sections
- Special Emphasis Panel[ZAI1 BP-A (J3)]4
Most frequent institutions
- HARVARD UNIVERSITY1
- UNIVERSITY OF CALIFORNIA LOS ANGELES1
- UNIVERSITY OF PENNSYLVANIA1
- UNIVERSITY OF SOUTHERN CALIFORNIA1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2015 | Next Generation HSC Gene Therapy for HIV Control and Eradication1U19HL129902-01 | CANNON, PAULA MKIEM, HANS-PETER | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $2,516,838 | ZAI1 |
| 2015 | Engineering T cells to Provide Durable Control of HIV-1 Replication1U19AI117950-01 | RILEY, JAMES L. | UNIVERSITY OF PENNSYLVANIA, PA | $2,335,132 | ZAI1 |
| 2015 | A defend and destroy approach to curing HIV1U19HL129903-01 | SCADDEN, DAVID T | HARVARD UNIVERSITY, MA | $2,327,582 | ZAI1 |
| 2015 | Anti-HIV Gene Therapy: Defend and Attack1U19AI117941-01 | CHEN, IRVIN S.Y. | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $2,256,106 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.